1,1-dichloroethene increases expression EXP 6480464 vinylidene chloride results in increased expression of CTTNBP2NL mRNA CTD PMID:26682919 1,2-dimethylhydrazine decreases expression EXP 6480464 1 and 2-Dimethylhydrazine results in decreased expression of CTTNBP2NL mRNA CTD PMID:22206623 1,2-dimethylhydrazine multiple interactions EXP 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CTTNBP2NL mRNA CTD PMID:22206623 1-naphthyl isothiocyanate increases expression ISO Cttnbp2nl (Rattus norvegicus) 6480464 1-Naphthylisothiocyanate results in increased expression of CTTNBP2NL mRNA CTD PMID:25380136 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of CTTNBP2NL mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Cttnbp2nl (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin results in increased expression of CTTNBP2NL mRNA CTD PMID:34747641 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO CTTNBP2NL (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of CTTNBP2NL mRNA CTD PMID:28628672 4,4'-diaminodiphenylmethane increases expression ISO Cttnbp2nl (Rattus norvegicus) 6480464 4 and 4'-diaminodiphenylmethane results in increased expression of CTTNBP2NL mRNA CTD PMID:25380136 and PMID:30723492 4,4'-sulfonyldiphenol multiple interactions ISO CTTNBP2NL (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of CTTNBP2NL mRNA CTD PMID:28628672 4-hydroxyphenyl retinamide increases expression EXP 6480464 Fenretinide results in increased expression of CTTNBP2NL mRNA CTD PMID:28973697 6-propyl-2-thiouracil increases expression ISO Cttnbp2nl (Rattus norvegicus) 6480464 Propylthiouracil results in increased expression of CTTNBP2NL mRNA CTD PMID:22504374 more ... acetamide increases expression ISO Cttnbp2nl (Rattus norvegicus) 6480464 acetamide results in increased expression of CTTNBP2NL mRNA CTD PMID:31881176 aflatoxin B1 affects expression ISO CTTNBP2NL (Homo sapiens) 6480464 Aflatoxin B1 affects the expression of CTTNBP2NL protein CTD PMID:20106945 amitrole increases expression ISO Cttnbp2nl (Rattus norvegicus) 6480464 Amitrole results in increased expression of CTTNBP2NL mRNA CTD PMID:30047161 arsane decreases expression EXP 6480464 Arsenic results in decreased expression of CTTNBP2NL mRNA CTD PMID:19654921 arsenic atom decreases expression EXP 6480464 Arsenic results in decreased expression of CTTNBP2NL mRNA CTD PMID:19654921 arsenite(3-) multiple interactions ISO CTTNBP2NL (Homo sapiens) 6480464 arsenite inhibits the reaction [G3BP1 protein binds to CTTNBP2NL mRNA] CTD PMID:32406909 arsenous acid decreases expression EXP 6480464 Arsenic Trioxide results in decreased expression of CTTNBP2NL mRNA CTD PMID:29095437 arsenous acid multiple interactions EXP 6480464 Metformin inhibits the reaction [Arsenic Trioxide results in decreased expression of CTTNBP2NL mRNA] CTD PMID:29095437 atrazine decreases expression ISO CTTNBP2NL (Homo sapiens) 6480464 Atrazine results in decreased expression of CTTNBP2NL mRNA CTD PMID:22378314 benzo[a]pyrene increases expression EXP 6480464 Benzo(a)pyrene results in increased expression of CTTNBP2NL mRNA CTD PMID:21569818 and PMID:22228805 benzo[a]pyrene affects methylation ISO CTTNBP2NL (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of CTTNBP2NL intron CTD PMID:30157460 benzo[a]pyrene increases methylation EXP 6480464 Benzo(a)pyrene results in increased methylation of CTTNBP2NL intron CTD PMID:27901495 benzo[a]pyrene increases methylation ISO CTTNBP2NL (Homo sapiens) 6480464 Benzo(a)pyrene results in increased methylation of CTTNBP2NL 5' UTR CTD PMID:27901495 benzo[a]pyrene diol epoxide I decreases expression ISO CTTNBP2NL (Homo sapiens) 6480464 7 more ... CTD PMID:19150397 Benzo[k]fluoranthene decreases expression EXP 6480464 benzo(k)fluoranthene results in decreased expression of CTTNBP2NL mRNA CTD PMID:26377693 bisphenol A increases expression ISO Cttnbp2nl (Rattus norvegicus) 6480464 bisphenol A results in increased expression of CTTNBP2NL mRNA CTD PMID:25181051 more ... cadmium atom multiple interactions ISO CTTNBP2NL (Homo sapiens) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CTTNBP2NL mRNA CTD PMID:35301059 cadmium dichloride multiple interactions ISO CTTNBP2NL (Homo sapiens) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CTTNBP2NL mRNA CTD PMID:35301059 caffeine decreases phosphorylation ISO CTTNBP2NL (Homo sapiens) 6480464 Caffeine results in decreased phosphorylation of CTTNBP2NL protein CTD PMID:35688186 carbon nanotube increases expression EXP 6480464 Nanotubes and Carbon results in increased expression of CTTNBP2NL mRNA CTD PMID:25554681 CGP 52608 multiple interactions ISO CTTNBP2NL (Homo sapiens) 6480464 CGP 52608 promotes the reaction [RORA protein binds to CTTNBP2NL gene] CTD PMID:28238834 chloroprene increases expression EXP 6480464 Chloroprene results in increased expression of CTTNBP2NL mRNA CTD PMID:23125180 chlorpyrifos increases expression EXP 6480464 Chlorpyrifos results in increased expression of CTTNBP2NL mRNA CTD PMID:37019170 copper(II) sulfate increases expression ISO CTTNBP2NL (Homo sapiens) 6480464 Copper Sulfate results in increased expression of CTTNBP2NL mRNA CTD PMID:19549813 coumarin affects phosphorylation ISO CTTNBP2NL (Homo sapiens) 6480464 coumarin affects the phosphorylation of CTTNBP2NL protein CTD PMID:35688186 coumestrol multiple interactions ISO CTTNBP2NL (Homo sapiens) 6480464 [Coumestrol co-treated with 2 more ... CTD PMID:19167446 cyclosporin A increases expression ISO CTTNBP2NL (Homo sapiens) 6480464 Cyclosporine results in increased expression of CTTNBP2NL mRNA CTD PMID:25562108 cyclosporin A decreases expression ISO CTTNBP2NL (Homo sapiens) 6480464 Cyclosporine results in decreased expression of CTTNBP2NL mRNA CTD PMID:27989131 dexamethasone multiple interactions ISO CTTNBP2NL (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of CTTNBP2NL mRNA CTD PMID:28628672 diarsenic trioxide multiple interactions EXP 6480464 Metformin inhibits the reaction [Arsenic Trioxide results in decreased expression of CTTNBP2NL mRNA] CTD PMID:29095437 diarsenic trioxide decreases expression EXP 6480464 Arsenic Trioxide results in decreased expression of CTTNBP2NL mRNA CTD PMID:29095437 dorsomorphin multiple interactions ISO CTTNBP2NL (Homo sapiens) 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CTTNBP2NL mRNA CTD PMID:27188386 doxorubicin decreases expression ISO CTTNBP2NL (Homo sapiens) 6480464 Doxorubicin results in decreased expression of CTTNBP2NL mRNA CTD PMID:29803840 endosulfan decreases expression ISO Cttnbp2nl (Rattus norvegicus) 6480464 Endosulfan results in decreased expression of CTTNBP2NL mRNA CTD PMID:29391264 Enterolactone multiple interactions ISO CTTNBP2NL (Homo sapiens) 6480464 [Coumestrol co-treated with 2 and 3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CTTNBP2NL mRNA CTD PMID:19167446 ethyl methanesulfonate increases expression ISO CTTNBP2NL (Homo sapiens) 6480464 Ethyl Methanesulfonate results in increased expression of CTTNBP2NL mRNA CTD PMID:23649840 fluoranthene multiple interactions EXP 6480464 [1-methylanthracene co-treated with fluoranthene] results in increased expression of CTTNBP2NL mRNA CTD PMID:28329830 folic acid multiple interactions EXP 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CTTNBP2NL mRNA CTD PMID:22206623 formaldehyde increases expression ISO CTTNBP2NL (Homo sapiens) 6480464 Formaldehyde results in increased expression of CTTNBP2NL mRNA CTD PMID:23649840 FR900359 decreases phosphorylation ISO CTTNBP2NL (Homo sapiens) 6480464 FR900359 results in decreased phosphorylation of CTTNBP2NL protein CTD PMID:37730182 furan increases expression ISO Cttnbp2nl (Rattus norvegicus) 6480464 furan results in increased expression of CTTNBP2NL mRNA CTD PMID:27387713 gentamycin decreases expression ISO Cttnbp2nl (Rattus norvegicus) 6480464 Gentamicins results in decreased expression of CTTNBP2NL mRNA CTD PMID:33387578 indometacin multiple interactions ISO CTTNBP2NL (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of CTTNBP2NL mRNA CTD PMID:28628672 inulin multiple interactions EXP 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of CTTNBP2NL mRNA CTD PMID:36331819 ivermectin decreases expression ISO CTTNBP2NL (Homo sapiens) 6480464 Ivermectin results in decreased expression of CTTNBP2NL protein CTD PMID:32959892 ketamine decreases expression ISO Cttnbp2nl (Rattus norvegicus) 6480464 Ketamine results in decreased expression of CTTNBP2NL mRNA CTD PMID:20080153 metformin multiple interactions EXP 6480464 Metformin inhibits the reaction [Arsenic Trioxide results in decreased expression of CTTNBP2NL mRNA] CTD PMID:29095437 methimazole increases expression ISO Cttnbp2nl (Rattus norvegicus) 6480464 Methimazole results in increased expression of CTTNBP2NL mRNA CTD PMID:22504374 and PMID:30047161 methyl methanesulfonate increases expression ISO CTTNBP2NL (Homo sapiens) 6480464 Methyl Methanesulfonate results in increased expression of CTTNBP2NL mRNA CTD PMID:23649840 methylmercury chloride decreases expression ISO CTTNBP2NL (Homo sapiens) 6480464 methylmercuric chloride results in decreased expression of CTTNBP2NL mRNA CTD PMID:28001369 N-nitrosodimethylamine increases expression ISO Cttnbp2nl (Rattus norvegicus) 6480464 Dimethylnitrosamine results in increased expression of CTTNBP2NL mRNA CTD PMID:25380136 oxaliplatin multiple interactions ISO Cttnbp2nl (Rattus norvegicus) 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of CTTNBP2NL mRNA CTD PMID:25729387 paracetamol affects expression EXP 6480464 Acetaminophen affects the expression of CTTNBP2NL mRNA CTD PMID:17562736 perfluorooctane-1-sulfonic acid multiple interactions EXP 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of CTTNBP2NL mRNA CTD PMID:36331819 pirinixic acid decreases expression EXP 6480464 pirinixic acid results in decreased expression of CTTNBP2NL mRNA CTD PMID:20813756 potassium dichromate increases expression EXP 6480464 Potassium Dichromate results in increased expression of CTTNBP2NL mRNA CTD PMID:23608068 resveratrol multiple interactions ISO CTTNBP2NL (Homo sapiens) 6480464 [Coumestrol co-treated with resveratrol] results in decreased expression of CTTNBP2NL mRNA CTD PMID:19167446 SB 431542 multiple interactions ISO CTTNBP2NL (Homo sapiens) 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CTTNBP2NL mRNA CTD PMID:27188386 silicon dioxide increases expression EXP 6480464 Silicon Dioxide results in increased expression of CTTNBP2NL mRNA CTD PMID:19073995 and PMID:33720480 Soman increases expression ISO Cttnbp2nl (Rattus norvegicus) 6480464 Soman results in increased expression of CTTNBP2NL mRNA CTD PMID:19281266 succimer multiple interactions EXP 6480464 [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CTTNBP2NL mRNA CTD PMID:21641980 sulfadimethoxine increases expression ISO Cttnbp2nl (Rattus norvegicus) 6480464 Sulfadimethoxine results in increased expression of CTTNBP2NL mRNA CTD PMID:30047161 sulforaphane decreases expression EXP 6480464 sulforaphane results in decreased expression of CTTNBP2NL mRNA CTD PMID:30529165 sunitinib decreases expression ISO CTTNBP2NL (Homo sapiens) 6480464 Sunitinib results in decreased expression of CTTNBP2NL mRNA CTD PMID:31533062 thioacetamide increases expression ISO Cttnbp2nl (Rattus norvegicus) 6480464 Thioacetamide results in increased expression of CTTNBP2NL mRNA CTD PMID:34492290 titanium dioxide increases expression EXP 6480464 titanium dioxide results in increased expression of CTTNBP2NL mRNA CTD PMID:23409001 topotecan multiple interactions ISO Cttnbp2nl (Rattus norvegicus) 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of CTTNBP2NL mRNA CTD PMID:25729387 topotecan increases expression ISO Cttnbp2nl (Rattus norvegicus) 6480464 Topotecan results in increased expression of CTTNBP2NL mRNA CTD PMID:25729387 triadimefon increases expression ISO Cttnbp2nl (Rattus norvegicus) 6480464 triadimefon results in increased expression of CTTNBP2NL mRNA CTD PMID:30047161 trichostatin A decreases expression ISO CTTNBP2NL (Homo sapiens) 6480464 trichostatin A results in decreased expression of CTTNBP2NL mRNA CTD PMID:24935251 trichostatin A affects expression ISO CTTNBP2NL (Homo sapiens) 6480464 trichostatin A affects the expression of CTTNBP2NL mRNA CTD PMID:28542535 triptonide increases expression EXP 6480464 triptonide results in increased expression of CTTNBP2NL mRNA CTD PMID:33045310 trovafloxacin increases expression EXP 6480464 trovafloxacin results in increased expression of CTTNBP2NL mRNA CTD PMID:35537566 urethane increases expression ISO CTTNBP2NL (Homo sapiens) 6480464 Urethane results in increased expression of CTTNBP2NL mRNA CTD PMID:28818685 valproic acid decreases methylation ISO CTTNBP2NL (Homo sapiens) 6480464 Valproic Acid results in decreased methylation of CTTNBP2NL gene CTD PMID:29154799 vancomycin decreases expression EXP 6480464 Vancomycin results in decreased expression of CTTNBP2NL mRNA CTD PMID:18930951 vinclozolin affects expression ISO Cttnbp2nl (Rattus norvegicus) 6480464 vinclozolin affects the expression of CTTNBP2NL mRNA CTD PMID:19015723 vorinostat multiple interactions ISO CTTNBP2NL (Homo sapiens) 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CTTNBP2NL mRNA CTD PMID:27188386